原发性远端肾小管酸中毒:优化代谢性酸中毒的纠正
本文阐述原发性远端肾小管酸中毒由集合管A型闰细胞小管转运缺陷导致排酸障碍,临床表现为慢性代谢性酸中毒相关并发症。早期持续碱剂治疗可预防这些表现,血浆碳酸氢盐目标应接近正常范围(23-28 mEq/L),儿童期获益明显但需终身治疗。
要点
- 原发性dRTA由集合管A型闰细胞转运缺陷致排酸障碍。
- 慢性代谢性酸中毒可致生长迟缓、骨异常、肾钙质沉着和结石。
- 碱剂治疗目标血浆碳酸氢盐23-28 mEq/L,需终身维持。
核心结论
- 早期持续碱剂纠正代谢性酸中毒可预防原发性dRTA的多种并发症。
主要发现
- 原发性dRTA的临床表型以慢性代谢性酸中毒并发症为主,包括生长迟缓、骨异常、肾钙质沉着和肾结石。
- 高钙尿和低枸橼酸尿是肾钙质沉着和肾结石发生的原因。
关键数值与推荐
- 血浆碳酸氢盐治疗目标应尽可能接近当前正常范围,即23至28 mEq/L。
临床怎么用
- 对原发性dRTA患者应早期并持续使用碱剂治疗,以纠正代谢性酸中毒。
- 儿童期即可显现碱剂治疗的多数获益,但需终身治疗以预防慢性代谢性酸中毒相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The term classic, type 1 renal tubular acidosis or primary distal renal tubular acidosis is used to designate patients with impaired ability to excrete acid normally in the urine as a result of tubular transport defects involving type A intercalated cells in the collecting duct. The clinical phenotype is largely characterized by the complications of chronic metabolic acidosis (MA): stunted growth, bone abnormalities, and nephrocalcinosis and nephrolithiasis that develop as the consequence of hypercalciuria and hypocitraturia. All these manifestations are preventable with early and sustained correction of MA with alkali therapy. The optimal target for plasma bicarbonate should be as close as possible to the range considered normal by current standards (between 23 and 28 mEq/L.). Most of the benefits of alkali therapy are tangible early in the course of the disease in childhood, but life-long treatment is required to prevent the vast array of complications attributable to chronic MA.
引用
- Medina E, Ariceta G, Batlle D, et al. Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic Acidosis. Clin J Am Soc Nephrol. 2024. PMID: 38967973. doi:10.2215/CJN.0000000000000535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。